Carboplatin

You have access
Safety and Efficacy of Platinum Agents plus Etoposide for Patients with Small Cell Lung Cancer with Interstitial Lung Disease
TATSUYA YOSHIDA, KIYOTAKA YOH, KOICHI GOTO, SEIJI NIHO, SHIGEKI UMEMURA, HIRONOBU OHMATSU and YUICHIRO OHE

Anticancer Research March 2013, 33 (3) 1175-1179;
You have access
Phase I Clinical and Pharmacokinetic Study of Bi-weekly Carboplatin/Paclitaxel Chemotherapy in Elderly Patients with Advanced Non-small Cell Lung Cancer
YUKARI TSUBATA, TAMIO OKIMOTO, KIYOTAKA MIURA, FUMI KARINO, SHINICHI IWAMOTO, MITSUHIRO TADA, TAKESHI HONDA, SHUNICHI HAMAGUCHI, MIKI OHE, AKIHISA SUTANI, TAKASHIGE KURAKI, AKINOBU HAMADA and TAKESHI ISOBE

Anticancer Research January 2013, 33 (1) 261-266;
You have access
Pemetrexed plus Carboplatin or Cisplatin as Neoadjuvant Treatment of Operable Malignant Pleural Mesothelioma (MPM)
GIULIA PASELLO, GIUSEPPE MARULLI, VALENTINA POLO, CRISTIANO BREDA, LAURA BONANNO, LUCIO LOREGGIAN, FEDERICO REA and ADOLFO FAVARETTO

Anticancer Research December 2012, 32 (12) 5393-5399;
You have access
Initial Activation Status of the Antioxidant Response Determines Sensitivity to Carboplatin/Paclitaxel Treatment of Ovarian Cancer
DANIEL G. PONS, JORGE SASTRE-SERRA, MERCEDES NADAL-SERRANO, AINA OLIVER, MAGDALENA GARCÍA-BONAFÉ, ISABEL BOVER, PILAR ROCA and JORDI OLIVER

Anticancer Research November 2012, 32 (11) 4723-4728;
You have access
The mTOR Inhibitor RAD001 Sensitizes Tumor Cells to the Cytotoxic Effect of Carboplatin in Breast Cancer In Vitro
HONGYU LIU, CHUANBING ZANG, JAN-HENDRIK SCHEFE, SANDRA SCHWARZLOSE-SCHWARCK, ANNE-CONSTANZE REGIERER, ELENA ELSTNER, CARSTEN-OLIVER SCHULZ, CHRISTIAN SCHOLZ, KURT POSSINGER and JAN EUCKER

Anticancer Research September 2011, 31 (9) 2713-2722;

Main menu

User menu

Search

Carboplatin

Pages